What Is BMAC Therapy? Bone Marrow Aspirate Concentrate Explained
Harness your body's most powerful regenerative cells for advanced musculoskeletal healing. BMAC therapy delivers concentrated mesenchymal stem cells, growth factors, and regenerative proteins directly from your own bone marrow to damaged tissue. This cellular based treatment is used where cartilage damage is severe, tendon tears are complex, or platelet therapy alone has not been enough. Evidence in these conditions is still developing. Where cellular repair is the goal, BMAC is intended to provide a biological foundation for that process. If you are looking for treatment, read about BMAC therapy in Atlanta at Paragon.

Cellular Regeneration.
Comprehensive Healing.
At Paragon Sports Medicine, we recognize that severe musculoskeletal conditions often need more than growth factors alone. Bone Marrow Aspirate Concentrate (BMAC) uses cells drawn from your own bone marrow. Unlike platelet-based therapies, which concentrate platelets and growth factors, BMAC also delivers mesenchymal stem cells. Laboratory studies show these cells are capable of differentiating into bone, cartilage and tendon cells. What that means for any individual patient is still being studied. The concentrated preparation includes MSCs, growth factors, cytokines and anti-inflammatory proteins. It is used for severe osteoarthritis, significant cartilage defects, avascular necrosis, complex rotator cuff tears, and conditions where previous treatments have not helped enough.

The Science Behind
Cellular Regeneration
BMAC delivers concentrated mesenchymal stem cells and regenerative proteins that work synergistically to rebuild damaged musculoskeletal tissue:
Mesenchymal Stem Cell Differentiation
In laboratory studies, MSCs from bone marrow can differentiate into bone cells (osteoblasts), cartilage cells (chondrocytes) and tendon cells (tenocytes). What that means for any individual patient is still being studied.
Growth Factor Cascade
Concentrated bone marrow releases BMP (bone morphogenetic protein), TGF-β, VEGF, PDGF, and IGF, stimulating cellular proliferation, matrix production, and vascularization.
Anti-Inflammatory Modulation
MSCs possess powerful immunomodulatory properties, reducing chronic inflammation that inhibits healing while creating an environment conducive to tissue regeneration.
Paracrine Signaling
Beyond direct differentiation, MSCs release bioactive factors that recruit native stem cells, enhance cellular activity, and orchestrate the entire healing cascade.
Structural Matrix Production
Differentiated cells produce collagen, proteoglycans, and extracellular matrix components that restore tissue architecture, mechanical strength, and functional capacity.


Advanced Cellular Therapy for
Complex Conditions
BMAC is generally reserved for cases where tissue damage is more severe, degenerative changes are more advanced, or previous treatments have not helped enough. It delivers concentrated cells from your own bone marrow rather than platelets alone. It is used for cartilage defects, avascular necrosis, and complex structural injuries. Whether BMAC or a platelet-based treatment makes more sense for you is a judgement Dr. Garten will make from your examination and imaging.
BMAC is studied in: Severe osteoarthritis and cartilage defects

Severe osteoarthritis & cartilage defects
Advanced joint degeneration, full-thickness cartilage loss, osteochondral lesions, and bone-on-bone arthritis. Laboratory studies show mesenchymal cells are capable of differentiating into cartilage cells. What that means for any individual patient is still being studied.

Avascular necrosis & bone conditions
AVN of the femoral head or other bones, non-union fractures, stress fractures that won't heal, and bone defects requiring osteoblast differentiation and new bone formation.

Complex tendon tears & structural damage
Large or retracted rotator cuff tears, Achilles ruptures, significant meniscal tears, and severe tendinopathy where cellular regeneration can restore tissue integrity.
Your Journey
to Cellular Regeneration
Pre-Procedure Preparation
You'll be positioned comfortably for access to the posterior iliac crest (back of the pelvis). The aspiration site is thoroughly cleaned and sterilized. Local anesthesia is administered to ensure comfort during bone marrow collection.
Bone Marrow Aspiration
Using a specialized needle, Dr. Garten carefully aspirates bone marrow from the posterior iliac crest. Multiple small aspirations (rather than one large draw) optimize stem cell concentration. The procedure is well-tolerated with local anesthesia and typically takes 15-20 minutes.
Centrifugation & Concentration
Your bone marrow is processed through specialized centrifugation protocols that concentrate mesenchymal stem cells, growth factors, and regenerative proteins while removing unnecessary components. This concentration process takes 30-45 minutes and yields the therapeutic BMAC formulation.
Ultrasound-Guided Injection
Using real-time musculoskeletal ultrasound imaging, Dr. Garten precisely identifies the damaged tissue and injects the concentrated BMAC directly into the target area – whether cartilage defect, bone lesion, or tendon tear – ensuring maximum cellular delivery to damaged tissue.
Recovery & Regeneration Protocol
You'll receive detailed activity modification guidelines, pain management strategies, and a phased rehabilitation plan optimized for cellular regeneration timelines. Follow-up imaging and assessments track tissue regeneration progress over subsequent months.

Understanding Your Cellular Regeneration Timeline
BMAC therapy initiates a biological regeneration process that unfolds over several months. Unlike medications that provide immediate symptom relief, cellular therapies require time for stem cells to differentiate, proliferate, and rebuild tissue. Understanding this timeline helps set realistic expectations and optimize your recovery.
Precision Expertise. Advanced Regenerative Medicine
BMAC therapy requires sophisticated technical skill, specialized equipment, and comprehensive understanding of cellular regeneration biology. Success depends on multiple critical factors that distinguish expert-level care:
With over two decades of experience in regenerative medicine and extensive training in advanced cellular therapies, Dr. Garten brings elite expertise to every BMAC procedure. His comprehensive approach to tissue regeneration gives you the absolute best opportunity for meaningful, lasting functional restoration.

Choosing the Right Regenerative Approach

COMPARISON 1: BMAC vs. PRP
When BMAC is preferred: PRP delivers concentrated platelets and growth factors. BMAC also delivers mesenchymal stem cells, and is generally chosen for more severe cartilage loss, bone defects and large structural tears. For moderate degenerative changes or tendon injuries, PRP is often the more proportionate option. Which one suits your case is a judgement Dr. Garten will make from your examination and imaging.
COMPARISON 2: BMAC vs. Surgery
Surgical alternatives: While surgery removes or replaces damaged tissue, BMAC stimulates your body to rebuild it biologically. BMAC avoids surgical risks, preserves native anatomy, requires no hardware or implants, and maintains future surgical options if needed. However, some conditions still require surgery, and Dr. Garten will honestly assess whether BMAC is appropriate for your specific situation.
COMPARISON 3: BMAC + PRP Combination
Synergistic approach: Some conditions benefit from combining BMAC's cellular regeneration with PRP's growth factor acceleration. Dr. Garten may recommend this combination for complex cases requiring both stem cell differentiation and enhanced healing signals. The therapies work synergistically – stem cells provide regenerative capacity while platelets create an optimal growth environment.
COMPARISON 4: BMAC vs. Adipose-Derived Therapy
Different cellular sources: Both BMAC and adipose (fat-derived) therapies provide mesenchymal stem cells, but from different sources. Bone marrow MSCs demonstrate stronger osteogenic (bone-forming) and chondrogenic (cartilage-forming) potential, making BMAC preferred for cartilage defects, bone conditions, and severe osteoarthritis. Adipose therapy offers easier harvest with higher cell yield but potentially different differentiation capacity. Dr. Garten selects the optimal cellular source based on your specific condition.
Cell-Based Treatment
Unlike therapies that only accelerate existing healing, BMAC delivers mesenchymal stem cells capable of differentiating into bone, cartilage, and tendon cells. This represents actual tissue rebuilding, not just symptom management.
Addresses Root Cause
Rather than masking pain or removing damaged tissue surgically, BMAC addresses the underlying tissue degeneration by providing the cellular building blocks necessary for biological reconstruction. This approach targets the source of dysfunction rather than just symptoms.
Autologous Safety Profile
BMAC uses only your own cells and growth factors, eliminating risks of rejection, disease transmission, or allergic reaction associated with donor tissues or synthetic materials. The autologous nature provides excellent safety with minimal risk profile.
Preserves Native Anatomy
Unlike surgical interventions that remove tissue or implant hardware, BMAC preserves your natural joint structure and mechanics. Native tissue preservation maintains proprioception, biomechanics, and long-term joint health while avoiding implant-related complications.
An injection-based option
BMAC is delivered as an injection using your own bone marrow. It does not involve a surgical incision, general anesthesia, or implanted hardware. Whether it is appropriate for your condition depends on your diagnosis and your imaging, and some conditions are better treated surgically.
Maintains Future Options
BMAC doesn't preclude future treatments. If regenerative therapy doesn't provide sufficient improvement, surgical options remain available. However, many patients achieve meaningful functional restoration with BMAC, avoiding surgery entirely or delaying it significantly.
The BMAC Advantage

Understanding BMAC:
The Essential FAQ
The bone marrow aspiration is performed under local anesthesia to ensure comfort. Most patients describe feeling pressure and a deep, brief ache during aspiration – similar to a bone bruise sensation – but report the procedure is well-tolerated and less uncomfortable than anticipated. Dr. Garten uses advanced anesthetic techniques and specialized aspiration protocols to minimize discomfort. The aspiration site (back of pelvis/hip) typically feels sore for 3-7 days afterward, similar to a deep bruise, but is manageable with ice and over-the-counter pain medication (avoiding NSAIDs). Many patients return to desk work within 1-2 days, though you should avoid strenuous activity involving the aspiration site for 1-2 weeks.
BMAC uses cells drawn from your own bone marrow, processed and injected during the same visit in our office. That makes it different from products derived from umbilical cord or amniotic tissue, which are donor-sourced and regulated differently, and from culture-expanded cells, which involve more-than-minimal manipulation and carry a different regulatory status again. Dr. Garten will explain exactly what is and is not in the preparation you would receive, and what is known about it.
Where patients respond, improvement can last, though how long varies with the condition treated and the individual. Many patients experience sustained improvement for multiple years as the regenerated tissue functions biologically. However, durability depends on multiple factors: condition severity, age, activity level, biomechanics, continued degenerative processes, and adherence to rehabilitation. BMAC doesn't stop aging or prevent future injury, but the regenerated tissue can provide meaningful long-term functional improvement. Some patients may eventually require additional treatment if degeneration progresses, though regenerated tissue often demonstrates better resilience than untreated degenerative tissue. Long-term outcomes are still being studied as BMAC represents relatively recent advancement in regenerative medicine.
Most patients receive a single BMAC treatment to initiate cellular regeneration. However, depending on condition severity and initial response, some may benefit from a second treatment 6-12 months later to augment regeneration. BMAC is not typically performed as a series like PRP, due to the more invasive harvest procedure and the longer regeneration timeline required for cells to differentiate and produce tissue. Dr. Garten assesses your response through clinical evaluation and imaging to determine if additional treatment is warranted. Some patients combine BMAC with subsequent PRP treatments to support the regeneration process without additional bone marrow harvest.
Success rates vary significantly based on the specific condition being treated, severity of tissue damage, patient age, and individual biological factors. Published outcomes vary widely and no reliable pooled success rate exists. Factors associated with better outcomes include younger age, less severe degeneration, good overall health, absence of inflammatory conditions, appropriate patient selection, and adherence to rehabilitation protocols. BMAC tends to be most effective for cartilage defects, early-to-moderate avascular necrosis, and conditions where viable tissue remains that can respond to cellular signals. Advanced bone-on-bone arthritis with complete cartilage loss and bone deformity may have lower success rates. Dr. Garten will provide realistic expectations based on your specific condition during consultation.
For many patients with moderate-to-severe osteoarthritis or avascular necrosis, success depends on degeneration severity, remaining cartilage, bone quality, joint alignment, and individual regenerative capacity. Patients with some remaining cartilage and earlier-stage disease tend to achieve better outcomes. Those with complete cartilage loss, significant bone deformity, or very advanced arthritis may still require surgery, though BMAC can be attempted first without compromising future surgical options. Allowing patients to delay surgery to an older age when they may be better prepared physically and mentally.
BMAC therapy costs are higher than PRP due to the more complex procedure, specialized processing equipment, sterile consumables, extended procedure time, and cellular therapy expertise required. Costs typically range significantly depending on the complexity of the condition being treated and whether combination therapies are used. Our office will provide transparent pricing during consultation. While BMAC represents a significant investment, many patients find it cost-effective compared to ongoing pain management, repeated injections, or surgical intervention with associated costs and recovery time. We provide documentation for HSA/FSA reimbursement.
Like most regenerative medicine procedures, BMAC is not typically covered by insurance and is considered an out-of-pocket expense. Insurance companies generally classify autologous cellular therapies as investigational despite growing clinical evidence and widespread use. Our office can provide itemized documentation and procedure codes for HSA/FSA accounts or for potential partial reimbursement submission, though coverage is not guaranteed. We recommend contacting your insurance provider directly to inquire about any coverage for autologous bone marrow concentrate procedures.
Yes, BMAC is often combined with other regenerative therapies for synergistic effect. Common combinations include:
BMAC + PRP: Stem cells provide regenerative capacity while platelets create optimal growth environment
BMAC + Lipoaspirate: Different MSC sources may complement each other for complex conditions
BMAC followed by PRP: Initial BMAC for cellular regeneration, then PRP 3-6 months later to support tissue maturation
BMAC + Peptide Therapy: Systemic peptides optimize healing capacity and cellular activity
BMAC + Physical Therapy: Essential for tissue maturation, load tolerance, and functional restoration
Dr. Garten designs personalized treatment protocols that may incorporate multiple modalities to optimize your regenerative outcome.
Ideal BMAC candidates typically have severe cartilage damage, significant tendon tears, avascular necrosis, or degenerative conditions where tissue regeneration is required and conservative treatments have proven insufficient. You may be a good candidate if you have moderate-to-severe osteoarthritis with remaining cartilage, full-thickness cartilage defects, early-stage avascular necrosis, large rotator cuff tears, or conditions requiring cellular therapy beyond what PRP can provide.
You're likely NOT a good candidate if you have active infection, blood disorders, complete bone-on-bone arthritis with severe deformity, unrealistic expectations, or unwillingness to follow the extended rehabilitation protocol cellular therapy requires. Dr. Garten conducts comprehensive evaluation including clinical examination, imaging review, and discussion of your goals to determine if BMAC is appropriate for your specific situation.
The bone marrow aspiration is performed under local anesthesia to ensure comfort. Most patients describe feeling pressure and a deep, brief ache during aspiration – similar to a bone bruise sensation – but report the procedure is well-tolerated and less uncomfortable than anticipated. Dr. Garten uses advanced anesthetic techniques and specialized aspiration protocols to minimize discomfort. The aspiration site (back of pelvis/hip) typically feels sore for 3-7 days afterward, similar to a deep bruise, but is manageable with ice and over-the-counter pain medication (avoiding NSAIDs). Many patients return to desk work within 1-2 days, though you should avoid strenuous activity involving the aspiration site for 1-2 weeks.
BMAC uses cells drawn from your own bone marrow, processed and injected during the same visit in our office. That makes it different from products derived from umbilical cord or amniotic tissue, which are donor-sourced and regulated differently, and from culture-expanded cells, which involve more-than-minimal manipulation and carry a different regulatory status again. Dr. Garten will explain exactly what is and is not in the preparation you would receive, and what is known about it.
Where patients respond, improvement can last, though how long varies with the condition treated and the individual. Many patients experience sustained improvement for multiple years as the regenerated tissue functions biologically. However, durability depends on multiple factors: condition severity, age, activity level, biomechanics, continued degenerative processes, and adherence to rehabilitation. BMAC doesn't stop aging or prevent future injury, but the regenerated tissue can provide meaningful long-term functional improvement. Some patients may eventually require additional treatment if degeneration progresses, though regenerated tissue often demonstrates better resilience than untreated degenerative tissue. Long-term outcomes are still being studied as BMAC represents relatively recent advancement in regenerative medicine.
Most patients receive a single BMAC treatment to initiate cellular regeneration. However, depending on condition severity and initial response, some may benefit from a second treatment 6-12 months later to augment regeneration. BMAC is not typically performed as a series like PRP, due to the more invasive harvest procedure and the longer regeneration timeline required for cells to differentiate and produce tissue. Dr. Garten assesses your response through clinical evaluation and imaging to determine if additional treatment is warranted. Some patients combine BMAC with subsequent PRP treatments to support the regeneration process without additional bone marrow harvest.
Success rates vary significantly based on the specific condition being treated, severity of tissue damage, patient age, and individual biological factors. Published outcomes vary widely and no reliable pooled success rate exists. Factors associated with better outcomes include younger age, less severe degeneration, good overall health, absence of inflammatory conditions, appropriate patient selection, and adherence to rehabilitation protocols. BMAC tends to be most effective for cartilage defects, early-to-moderate avascular necrosis, and conditions where viable tissue remains that can respond to cellular signals. Advanced bone-on-bone arthritis with complete cartilage loss and bone deformity may have lower success rates. Dr. Garten will provide realistic expectations based on your specific condition during consultation.
For many patients with moderate-to-severe osteoarthritis or avascular necrosis, success depends on degeneration severity, remaining cartilage, bone quality, joint alignment, and individual regenerative capacity. Patients with some remaining cartilage and earlier-stage disease tend to achieve better outcomes. Those with complete cartilage loss, significant bone deformity, or very advanced arthritis may still require surgery, though BMAC can be attempted first without compromising future surgical options. Allowing patients to delay surgery to an older age when they may be better prepared physically and mentally.
BMAC therapy costs are higher than PRP due to the more complex procedure, specialized processing equipment, sterile consumables, extended procedure time, and cellular therapy expertise required. Costs typically range significantly depending on the complexity of the condition being treated and whether combination therapies are used. Our office will provide transparent pricing during consultation. While BMAC represents a significant investment, many patients find it cost-effective compared to ongoing pain management, repeated injections, or surgical intervention with associated costs and recovery time. We provide documentation for HSA/FSA reimbursement.
Like most regenerative medicine procedures, BMAC is not typically covered by insurance and is considered an out-of-pocket expense. Insurance companies generally classify autologous cellular therapies as investigational despite growing clinical evidence and widespread use. Our office can provide itemized documentation and procedure codes for HSA/FSA accounts or for potential partial reimbursement submission, though coverage is not guaranteed. We recommend contacting your insurance provider directly to inquire about any coverage for autologous bone marrow concentrate procedures.
Yes, BMAC is often combined with other regenerative therapies for synergistic effect. Common combinations include:
BMAC + PRP: Stem cells provide regenerative capacity while platelets create optimal growth environment
BMAC + Lipoaspirate: Different MSC sources may complement each other for complex conditions
BMAC followed by PRP: Initial BMAC for cellular regeneration, then PRP 3-6 months later to support tissue maturation
BMAC + Peptide Therapy: Systemic peptides optimize healing capacity and cellular activity
BMAC + Physical Therapy: Essential for tissue maturation, load tolerance, and functional restoration
Dr. Garten designs personalized treatment protocols that may incorporate multiple modalities to optimize your regenerative outcome.
Ideal BMAC candidates typically have severe cartilage damage, significant tendon tears, avascular necrosis, or degenerative conditions where tissue regeneration is required and conservative treatments have proven insufficient. You may be a good candidate if you have moderate-to-severe osteoarthritis with remaining cartilage, full-thickness cartilage defects, early-stage avascular necrosis, large rotator cuff tears, or conditions requiring cellular therapy beyond what PRP can provide.
You're likely NOT a good candidate if you have active infection, blood disorders, complete bone-on-bone arthritis with severe deformity, unrealistic expectations, or unwillingness to follow the extended rehabilitation protocol cellular therapy requires. Dr. Garten conducts comprehensive evaluation including clinical examination, imaging review, and discussion of your goals to determine if BMAC is appropriate for your specific situation.
Schedule a
consultation
We don't just treat injuries – we help regenerate tissue and restore your body's full potential. Whether you're facing severe joint degeneration, complex structural damage, or have exhausted other treatment options, our cellular regenerative programs are built on clinical expertise, current biology, and carefully selected protocols.
Our comprehensive approach combines advanced diagnostics, precise ultrasound-guided delivery, personalized rehabilitation, and integrative recovery strategies to support your body's regenerative capacity at every stage. Healing at the cellular level isn't accidental – it's intentional.
Adipose and bone marrow derived cell therapies are not FDA approved for the treatment of any orthopedic condition. Their use here is based on clinical judgment and the current published evidence, which is still developing. Individual results vary.
Schedule a
consultation
We don't just treat injuries – we help regenerate tissue and restore your body's full potential. Whether you're facing severe joint degeneration, complex structural damage, or have exhausted other treatment options, our cellular regenerative programs are built on clinical expertise, current biology, and carefully selected protocols.
Our comprehensive approach combines advanced diagnostics, precise ultrasound-guided delivery, personalized rehabilitation, and integrative recovery strategies to support your body's regenerative capacity at every stage. Healing at the cellular level isn't accidental – it's intentional.
Adipose and bone marrow derived cell therapies are not FDA approved for the treatment of any orthopedic condition. Their use here is based on clinical judgment and the current published evidence, which is still developing. Individual results vary.